Printed From BioPortfolio.com

2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients

14:00 EST 4 Dec 2017 | Drug Discovery Development

News

The development of therapeutic approaches for patients with lung cancer has been a critical medical need.

Contributed Author:

Johns Hopkins Kimmel Cancer Center

Topics:

Drug Discovery

Original Article: 2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients

More From BioPortfolio on "2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Cancer
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches